WPRIM Management System> DCMS> Blood Research> 2022> 57> 1

Volume: 57 Issue: 1

1. Dasatinib-induced reversible pulmonary arterial hypertension in a pediatric patient with BCR/ABL1+ lymphoblastic lymphoma from chronic myeloid leukemia Page:80—84
2. Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second Page:76—80
3. COVID-19 pneumonia concurrent with newly diagnosed chronic myelogenous leukemia Page:74—75
4. Myeloproliferative neoplasm with basophilia and abnormality of platelet-derived growth factor receptor a translocation: a case report Page:69—74
5. Myelofibrotic and leukemic transformation in 2016 WHO-defined Philadelphia-negative myeloproliferative neoplasm Page:59—68
6. Real-world evidence of levofloxacin prophylaxis in elderly patients with newly diagnosed multiple myeloma who received bortezomib, melphalan, and prednisone regimen Page:51—58
7. Clinical characteristics and treatment outcomes of children and adolescents with aggressive mature B-cell lymphoma: a single-center analysis Page:41—50
8. Prophylaxis for invasive fungal infection in pediatric patients with allogeneic hematopoietic stem cell transplantation Page:34—40
9. Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more impact than disease biology? Page:29—33
10. Management of immune thrombocytopenia: 2022 update of Korean experts recommendations Page:20—28
11. IDH1/2 mutations in acute myeloid leukemia Page:13—19
12. Convalescent plasma in COVID-19: renewed focus on the timing and effectiveness of an old therapy Page:6—12
13. ALK-positive anaplastic large cell lymphoma that presented as pleural effusion Page:5—5
14. Appearances are deceiving: immature lymphocytes in Leishmaniasis Page:4—4
15. A call for vigilance: thrombotic thrombocytopenic syndrome caused by mRNA COVID-19vaccine associated with muscle weakness Page:1—3